Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
City of Hope Medical Center
City of Hope Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
University of Washington
Weill Medical College of Cornell University
Ohio State University Comprehensive Cancer Center